Impilo Pharmaceuticals Private Limited

Impilo Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U24232KA2015PTC078093 Incorporated 05 January 2015 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2019
₹51.17 Lakh
▲ 20% YoY
Net profit · FY 2019
₹1.49 Lakh
Net margin 2.9%
EBITDA · FY 2019
₹2.98 Lakh
EBITDA margin 5.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
6
As per MCA filings
Active GSTINs
1
GST registered

About Impilo Pharmaceuticals Private Limited

Data last updated:

Impilo Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2015PTC078093. Its GSTIN is 29AADCI7118K1Z9 (Karnataka).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Kannambadi Thammaiah Subramaniam (Managing Director) and Vijay Mathodu Eshwarappa (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Shed No. 101 1st Floor Ind Esta Rajajinagar, Bangalore, Karnataka, India – 560010.

As per the financials filed for FY 2019, the company reported a revenue of ₹51.17 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Lakh (net margin 2.9%) and EBITDA of ₹2.98 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years.

Court records list 1 case involving the company, including 1 filed against it.

Impilo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0068545). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website impilopharma.in.

Company Details of Impilo Pharmaceuticals Private Limited
CIN U24232KA2015PTC078093
Registration Number 078093
Incorporation Date 05 January 2015
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2019
Date of Balance Sheet 31 March 2019
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0068545
Key People
Kannambadi Thammaiah Subramaniam Managing Director Vijay Mathodu Eshwarappa Whole-Time Director Aruna Mallippanahalli Dharmeshappa Whole-Time Director

Recognitions & Rankings of Impilo Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-KR-03-0068545
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    impilopharma.in
  • Social Media
  • Registered Address
    Shed No. 101 1st Floor Ind Esta Rajajinagar, Bangalore, Karnataka, India – 560010
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Impilo Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full report on Impilo Pharmaceuticals

Financials, compliance, directors, charges, ownership and filings for Impilo Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity

The main business activity of Impilo Pharmaceuticals is trade. In detail, this covers retail trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG2Retail TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Financials of Impilo Pharmaceuticals Private Limited

FY 2019 filings available

Impilo Pharmaceuticals Private Limited reported revenue of ₹51.17 Lakh (up 20% YoY) for FY 2019.

Revenue · FY 2019
₹51.17 Lakh ▲ 20%
Net profit · FY 2019
₹1.49 Lakh margin 2.9%
EBITDA · FY 2019
₹2.98 Lakh margin 5.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 45%
EBITDA CAGR growth
1 year
▲ 80%
3 years · compounded
▲ 77%

Revenue has grown at a compounded annual rate (CAGR) of 45% over three years, including 20% growth in the latest year. EBITDA rose 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2018-19FY 2014-15 to FY 2017-18in the company report
Profit and Loss Statement
Revenue from Operations₹51.17 Lakh
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA₹2.98 Lakh
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)₹1.49 Lakh
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios

MetricsFY 2018-19FY 2014-15 to FY 2017-18in the company report
Profitability
EBITDA Margin5.8%
Net Profit Margin2.9%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots, and every line for FY 2014-15 to FY 2017-18, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Impilo Pharmaceuticals are in the company report.

Financial statements from 2015: available in the company report

Board of Directors of Impilo Pharmaceuticals Private Limited

Impilo Pharmaceuticals has 6 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sandhya Ashish ShingeAdditional Director02 Aug 201610 Years 2 MonthsCurrent
Vijay Mathodu EshwarappaWhole-Time Director05 Jan 201511 Years 9 MonthsCurrent
Aruna Mallippanahalli DharmeshappaWhole-Time Director05 Jan 201511 Years 9 MonthsCurrent
Kannambadi Thammaiah SubramaniamManaging Director05 Jan 201511 Years 9 MonthsCurrent
Pradeep Tokasandra SiddegowdaWhole-Time Director05 Jan 201511 Years 9 MonthsCurrent
Ravishankar KrishnamurthyWhole-Time Director05 Jan 201511 Years 9 MonthsCurrent
View all directors

Auditor Details

Impilo Pharmaceuticals Private Limited is audited by N RAVI & CO for the financial year 2019.

NameStatusAppointment DateCessation Date
N RAVI & COLockedLockedLocked

Complete auditor history: available in the company report

Ownership and Shareholding

Shareholding and ownership data: available in the company report

Charges & Borrowings

Impilo Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance

Employment history and EPFO contributions of people linked to Impilo Pharmaceuticals.

Employee and EPFO history: available in the company report

Recent Activity

Impilo Pharmaceuticals Private Limited has 6 board changes on record since 2015: 6 appointments. The latest: Sandhya Ashish Shinge was appointed as Additional Director on 02 Aug 2016.

AGM
Impilo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records.
Filing
Impilo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore.
Appointed
Sandhya Ashish Shinge was appointed as Additional Director.
Appointed
Aruna Mallippanahalli Dharmeshappa was appointed as Whole-Time Director.
Appointed
Kannambadi Thammaiah Subramaniam was appointed as Managing Director.
Appointed
Pradeep Tokasandra Siddegowda was appointed as Whole-Time Director.
Appointed
Ravishankar Krishnamurthy was appointed as Whole-Time Director.
Appointed
Vijay Mathodu Eshwarappa was appointed as Whole-Time Director.
Incorporation
05 Jan 2015
Impilo Pharmaceuticals Private Limited was registered on 05 Jan 2015 with Roc Bangalore & aged 11 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts

Credit ratings, litigation, and regulatory alerts: available in the company report

MSME Payment Delays

MSME payment history: available in the company report

Subsidiaries & Group Companies

Corporate group structure: available in the company report

GST Compliance

Impilo Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AADCI7118K1Z9KarnatakaActive01 Jul 2017

GST registrations and filing compliance: available in the company report

MCA Filings & Documents

MCA filings and documents: available in the company report

Frequently Asked Questions

Impilo Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2015 (11+ years old) and is registered under CIN U24232KA2015PTC078093.

Impilo Pharmaceuticals has 6 current directors:

The latest financial statements of Impilo Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.

The GSTIN of Impilo Pharmaceuticals is 29AADCI7118K1Z9, registered in Karnataka.

The CIN (Corporate Identification Number) of Impilo Pharmaceuticals is U24232KA2015PTC078093. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Impilo Pharmaceuticals has 1 court case on record: 1 filed against it.

Impilo Pharmaceuticals was incorporated on 05 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.

Sandhya Ashish Shinge was appointed as Additional Director on 02 Aug 2016. Aruna Mallippanahalli Dharmeshappa was appointed as Whole-Time Director on 05 Jan 2015. Kannambadi Thammaiah Subramaniam was appointed as Managing Director on 05 Jan 2015. Impilo Pharmaceuticals has 6 board changes on record in total.

Yes, Impilo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0068545).

Impilo Pharmaceuticals can be reached through the website impilopharma.in. Its registered office is in Bangalore, Karnataka, India.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available